> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Notifying CDRH on Discontinued Products
- URL: https://www.fdaweb.com/guide-on-notifying-cdrh-on-discontinued-products/
- Published: 2020-06-22T12:00:00.000Z
- Updated: 2026-09-14T16:19:01.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5147062

FDA has updated a guidance entitled[ “Notifying CDRH of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act During the COVID-19 Public Health Emergency](https://u7061146.ct.sendgrid.net/ls/click?upn=LHDupLGQbJrIBf0glmWFG56-2F5cjxsvy-2BRYfSGVpJePD7HtQ-2FDW20Nz0QZZNd-2FDHbxsVWIce76QdD7DsAi12T290CR1pcy2oVRvac75mAWl6hCgGKmeCBzOZjLj3zZtljgu4Q2Dcia7OSiwtNQ9i-2FUIOen4HyFBLjCBRLYpGu7apDfn9LjRnQ-2BfHvOvT99kFHK-2FHnaG1Yl48ZkG7ABDWrwY90Lxc2hSL6BFLKoZuwjL57qssXG8RgKKGhjYozQWhOT9uEMaozTpxhCe3rSsgA57fwsWnVOHVWaWQ-2FIwXtt-2FmYflXA1UOmjxjKTzVTv-2BYaxiAoeGZg-2BKUdOatUzO1ueeENNjynPwTux17Nq5wwrjJz9ABYp2AUlBbrI4NGsEAgByK2fh8XiLXmK-2BL6J8-2FiMkywbrPx-2BQjQCEGHwrLAT2Q-3DJMFT%5Ff0D7hj0BJ4b-2F7NuVqzPDs7FGiq8VLIwAX0sPSotqoLIZH-2BlHUpIN1Fpx16wXLzBItZQB-2B865N-2BRM-2FfR3UV9b-2B-2Bk4OtA9jD9Cf2kF2Wjg6Tm-2FHdPlCJifJqUB7veM-2FkOzYHnEaWVklgtSJwfPbd-2FPcDAOGGt394CZIO8QGNs5bjqWdv7l1RIy30FGuQholyj5jGIA3jWtokRO2we1bCBjlaVJyk5AkHweozBq-2BU9UkZsYkZcYnpZ08pcGarpIERrrBEnqZBNFyDrXxTqgAk-2BJrqaJQUaEeXNxRzo-2BSKKXgUtYAyu6RKBErCA20zrLz9RmM8HxaauENbekwVILrRd7ej1SZjHjQUc1ys2LPd0aefk-3D&ref=fdaweb.com).” The document was updated to include a[ list of device types and corresponding product codes](https://u7061146.ct.sendgrid.net/ls/click?upn=LHDupLGQbJrIBf0glmWFG56-2F5cjxsvy-2BRYfSGVpJePD7HtQ-2FDW20Nz0QZZNd-2FDHbxsVWIce76QdD7DsAi12T290CR1pcy2oVRvac75mAWl6hCgGKmeCBzOZjLj3zZtljgu4Q2Dcia7OSiwtNQ9i-2FUIOen4HyFBLjCBRLYpGu7apDfn9LjRnQ-2BfHvOvT99kFHK-2FHnaG1Yl48ZkG7ABDWrwY90Lxc2hSL6BFLKoZuwjL57qssXG8RgKKGhjYozQWhOeFUvc6af3pnvvI0qb9DgHS8md-2B0cFhmUaL9kyYZacpmyEKHxa7rdM2L1PDr9N2yXWZSsDBGLNuA8LuLU33nn9PePSl7apPRO-2FDGHWwKY3MXZ1Uczd9DLO0WzEJEvCbwdL7JTTrMJBhhjMST-2FBGA1t7NUbVbpI3E5v4VaqnwXG64-3D2rEW%5Ff0D7hj0BJ4b-2F7NuVqzPDs7FGiq8VLIwAX0sPSotqoLIZH-2BlHUpIN1Fpx16wXLzBItZQB-2B865N-2BRM-2FfR3UV9b-2B-2Bk4OtA9jD9Cf2kF2Wjg6Tm-2FHdPlCJifJqUB7veM-2FkOzYHnEaWVklgtSJwfPbd-2FPcDAOGGt394CZIO8QGNs5bjqWdv7l1RIy30FGuQholyj5M5U1IfAI5gOAOxDVBrDOAOIFnBbWoCH0wfBe1Ug2qec0LP3N-2B3C3tltK8qbgheF88cN58a9n1FSKxC8HFqtqT6bujTbdNneyq-2Bk2ViDMNs66hrqbkZxR8B803zRE2dRH-2FessdxeufWyKOaBh35DWsmztmZU3o2snHuiUKWbQYI0-3D&ref=fdaweb.com) that the agency recommends manufacturers consider in determining whether a notification under Section 506(j) of the FD&C Act is required during the Covid-19 pandemic.